Shopping Cart
- Remove All
Your shopping cart is currently empty
SB 452533 is an antagonist of the vanilloid receptor 1(pKb: 7.8).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $35 | In Stock | |
| 5 mg | $58 | In Stock | |
| 10 mg | $98 | In Stock | |
| 25 mg | $193 | In Stock | |
| 50 mg | $298 | In Stock | |
| 100 mg | $433 | In Stock | |
| 200 mg | $616 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $71 | In Stock |
| Description | SB 452533 is an antagonist of the vanilloid receptor 1(pKb: 7.8). |
| Targets&IC50 | TRPV1:7.8(pKb) |
| In vitro | SB 452533 significantly reduced Capsaicin-induced phosphorylation of AMPK and CAMKK2[1]. |
| In vivo | Small dose Cap significantly reduced bleomycin-induced pulmonary fibrosis in mice and obviously reversed alveolar epithelial cells epithelial-mesenchymal transition (EMT) (the expression of E-cadherin and ZO-1 were increased(P<0.05 or P<0.01)and the expression of α-SMA and Vimentin were decreased (P<0.05 or P<0.01) after drugs treatment for 21 day, concomitantly with the increase the expressions of TRPV1 and CGRP (P<0.05 or P<0.01), and inhibiting ERK1/2 phosphorylation and eIF3a expression (P<0.05 or P<0.01). These effects of small dose Cap were abolished in the presence of TRPV1 receptor antagonist SB 452533[2]. |
| Molecular Weight | 376.29 |
| Formula | C18H22BrN3O |
| Cas No. | 459429-39-1 |
| Smiles | CCN(CCNC(=O)Nc1ccccc1Br)c1cccc(C)c1 |
| Relative Density. | 1.347 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 60 mg/mL (159.45 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.